Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 21, 2016
Biovest International Inc. announced that it will spin off its instrument and contract manufacturing offerings into a single wholly-owned subsidiary named “Cell Culture Company, LLC.” Cell Culture Company will supply automated single-use perfusion ...
read more
Bioversys AG and Aptuit have announced the start of a joint collaboration aimed at the identification and validation of novel targets and molecules for Gram-negative bacteria. Aptuit and BioVersys hope that innovative approaches can address ...
read more
Thursday, December 14, 2017
BioVectra announced a long-term supply agreement with Keryx Biopharmaceuticals to manufacture Ferric Citrate.
read more
BioVectra announced its fourth cGMP facility will be fully operational by December 2017.
read more
BIOVECTRA has broken ground on a cutting-edge facility that will manufacture mRNA vaccines and therapeutics starting in 2023.
read more
Thursday, October 05, 2023
BIOVECTRA and Acuitas Therapeutics, Inc. announced that they have entered into a technology transfer service agreement under which BIOVECTRA will accept, on a non-exclusive basis, Acuitas’ best-in-class LNP technology platform for manufacturing mRNA-...
read more
Thursday, November 18, 2021
BIOVECTRA has announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of mRNA vaccines and therapeutics – one of the first of its kind in Canada.
read more
BioVectra announced a five-year, $144.6 million (CAD) expansion project to enhance its Biopharmaceutical capabilities in both Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
read more
Saturday, September 25, 2021
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing and BIOVECTRA, a CDMO specializing in clinical-to-commercial scale production of high-quality regulated Biologics, Active Pharmaceutical Ingredients, and...
read more
BioVaxys has entered into an agreement with Bioanalytical Systems to conduct preclinical toxicology studies for its Covid-T immunodiagnostic.
read more
Tuesday, December 17, 2024
BioVaxys Technology Corp. announced that in anticipation of restarting clinical studies of various DPX formulations and initiating new preclinical studies, it has acquired a 48-kilogram ("kg") supply of GMP-grade lipid to enable production of the ...
read more
BioVaxys announced that its bioproduction partner Bio Elpida of Lyon, France, has initiated the construction of a new Good Manufacturing Practice ("GMP") cleanroom facility needed for producing the clinical supply of BVX-0918A, BioVaxys' ovarian ...
read more
Wednesday, December 07, 2016
Biothera Pharmaceuticals has announced an expansion of its research collaboration with Merck (known as MSD outside the United States and Canada) to include a Phase 2 clinical study investigating Biothera’s Imprime PGG in combination with KEYTRUDA® (...
read more
Saturday, January 28, 2017
Biotest Pharmaceuticals Corporation has announced the relocation of its Gainesville plasma collection center to 2315 NW 13th Street, Gainesville, Florida. The 15,000 square foot state-of-the-art facility officially opened its doors for business on ...
read more
Tuesday, January 15, 2013
Biotest Pharmaceuticals Corp. (BPC), a wholly owned U.S. subsidiary of Biotest AG (Dreieich, Germany), today announced it has entered into a strategic long-term manufacturing, supply, and license agreement with ADMA Biologics,Inc.(ADMA).
read more